Merus NV (MRUS)
46.95
-1.79
(-3.67%)
USD |
NASDAQ |
May 08, 16:00
46.95
0.00 (0.00%)
After-Hours: 16:41
Merus Shareholders Equity (Quarterly): 356.34M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 356.34M |
| September 30, 2023 | 393.39M |
| June 30, 2023 | 257.40M |
| March 31, 2023 | 217.52M |
| December 31, 2022 | 247.06M |
| September 30, 2022 | 298.78M |
| June 30, 2022 | 326.61M |
| March 31, 2022 | 297.47M |
| December 31, 2021 | 316.20M |
| September 30, 2021 | 205.77M |
| June 30, 2021 | 219.09M |
| March 31, 2021 | 236.54M |
| December 31, 2020 | 102.26M |
| September 30, 2020 | 84.50M |
| June 30, 2020 | 100.30M |
| March 31, 2020 | 114.59M |
| December 31, 2019 | 131.30M |
| September 30, 2019 | 77.00M |
| Date | Value |
|---|---|
| June 30, 2019 | 87.29M |
| March 31, 2019 | 97.66M |
| December 31, 2018 | 105.86M |
| September 30, 2018 | 98.68M |
| June 30, 2018 | 107.38M |
| March 31, 2018 | 117.58M |
| December 31, 2017 | 67.89M |
| September 30, 2017 | 70.15M |
| June 30, 2017 | 83.23M |
| March 31, 2017 | 97.55M |
| December 31, 2016 | 35.79M |
| September 30, 2016 | 71.51M |
| June 30, 2016 | 76.04M |
| March 31, 2016 | 26.29M |
| December 31, 2015 | 30.94M |
| September 30, 2015 | 38.41M |
| June 30, 2015 | -9.417M |
| December 31, 2014 | -4.328M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
77.00M
Minimum
Sep 2019
393.39M
Maximum
Sep 2023
214.18M
Average
219.09M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| argenx SE | 4.098B |
| uniQure NV | 207.67M |
| ProQR Therapeutics NV | 45.75M |
| Pharming Group | 218.78M |
| Pharvaris NV | 424.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 455.49M |
| Total Liabilities (Quarterly) | 99.15M |
| Current Ratio | 5.338 |